New partnerships and study collaborations, the events where you'll find us, and our thinking on tumour-informed ctDNA and where it's taking cancer care.
Gothenburg 2024-10-25: Simsen Diagnostics has signed an agreement with Docrates, a private cancer center in Finland. The agreement allows Docrates to …
A few weeks ago, we had the opportunity to meet with Ola Nilsson, Head of Neoantigen Production & Development at Neogap Therapeutics, to discuss t…
As we approach summer and vacations (at least for some of us in the office and most industry people here in Sweden), we wanted to take a moment to loo…
Gothenburg, 2024-06-26 – Simsen Diagnostics is announcing a new exciting collaboration with Orion Corporation, a Finnish pharmaceutical company, durin…
Gothenburg 2024-04-23 – Simsen Diagnostics announces having received a Vinnova grant through the strategic innovation program Swelife to strengthen Li…
Tell us about your study and your endpoints. A real scientist in CET/CEST will reply.
